全文获取类型
收费全文 | 7724篇 |
免费 | 2896篇 |
国内免费 | 82篇 |
专业分类
林业 | 325篇 |
农学 | 617篇 |
基础科学 | 79篇 |
1613篇 | |
综合类 | 728篇 |
农作物 | 198篇 |
水产渔业 | 2096篇 |
畜牧兽医 | 3074篇 |
园艺 | 125篇 |
植物保护 | 1847篇 |
出版年
2024年 | 8篇 |
2023年 | 14篇 |
2022年 | 17篇 |
2021年 | 150篇 |
2020年 | 506篇 |
2019年 | 955篇 |
2018年 | 828篇 |
2017年 | 899篇 |
2016年 | 716篇 |
2015年 | 680篇 |
2014年 | 655篇 |
2013年 | 920篇 |
2012年 | 1052篇 |
2011年 | 685篇 |
2010年 | 591篇 |
2009年 | 318篇 |
2008年 | 342篇 |
2007年 | 197篇 |
2006年 | 176篇 |
2005年 | 175篇 |
2004年 | 140篇 |
2003年 | 142篇 |
2002年 | 127篇 |
2001年 | 114篇 |
2000年 | 121篇 |
1999年 | 35篇 |
1998年 | 14篇 |
1997年 | 19篇 |
1996年 | 17篇 |
1995年 | 21篇 |
1994年 | 12篇 |
1993年 | 6篇 |
1992年 | 9篇 |
1991年 | 7篇 |
1990年 | 10篇 |
1989年 | 7篇 |
1988年 | 5篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1977年 | 1篇 |
1976年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
121.
Comparison of 4 point‐of‐care blood gas analyzers for arterial blood gas analysis in healthy dogs and dogs with cardiopulmonary disease 下载免费PDF全文
122.
123.
124.
125.
ASVCP guidelines: quality assurance for portable blood glucose meter (glucometer) use in veterinary medicine 下载免费PDF全文
Karen L. Gerber Kathleen P. Freeman 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》2016,45(1):10-27
Portable blood glucose meters (PBGM, glucometers) are a convenient, cost effective, and quick means to assess patient blood glucose concentration. The number of commercially available PBGM is constantly increasing, making it challenging to determine whether certain glucometers may have benefits over others for veterinary testing. The challenge in selection of an appropriate glucometer from a quality perspective is compounded by the variety of analytic methods used to quantify glucose concentrations and disparate statistical analysis in many published studies. These guidelines were developed as part of the ASVCP QALS committee response to establish recommendations to improve the quality of testing using point‐of‐care testing (POCT) handheld and benchtop devices in veterinary medicine. They are intended for clinical pathologists and laboratory professionals to provide them with background knowledge and specific recommendations for quality assurance (QA) and quality control (QC), and to serve as a resource to assist the provision of advice to veterinarians and technicians to improve the quality of results obtained when using PBGM. These guidelines are not intended to be all‐inclusive; rather they provide a minimum standard for management of PBGM in the veterinary setting. 相似文献
126.
Saverio Paltrinieri Luigi Gradoni Xavier Roura Andrea Zatelli Eric Zini 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》2016,45(4):552-578
Although several reviews on canine leishmaniasis have been published, none thoroughly described clinicopathologic abnormalities and their clinical usefulness. The aim of this review was to provide information concerning current diagnostic tests relevant for clinical pathologists and from a practical perspective. Specifically, in canine leishmaniasis, nonregenerative normocytic normochromic anemia, thrombocytopenia, or leukogram changes may be present. Clinical chemistry and urinalysis may indicate renal dysfunction (azotemia, decreased urine specific gravity, proteinuria) and an inflammatory/immune response (increased acute phase proteins [APP] or α2‐ and/or γ‐globulins). Although a potential gammopathy is usually polyclonal, it may also appear oligo‐ or monoclonal, especially in dogs coinfected by other vector‐borne pathogens. When lesions are accessible to fine‐needle aspiration (lymphoadenomegaly, nodular lesions, joint swelling), cytology is strongly advised, as the presence of Leishmania amastigotes in a pattern of pyogranulomatous inflammation or lymphoplasmacytic hyperplasia is diagnostic. If the cytologic pattern is inconclusive, the parasite should be identified by histology/immunohistochemistry or PCR on surgical biopsies. Alternatively, cytology and PCR may be performed on bone marrow samples where amastigotes, along with erythroid hypoplasia, myeloid hyperplasia, plasmacytosis, or secondary dysmyelopoiesis can be observed. Dogs with overt leishmaniasis generally have high antibody titers, while low titers predominate in immunologically resistant infected dogs or in exposed dogs with no parasite confirmation. Quantitative serology is recommended in clinically suspect dogs as high‐titer antibodies titers may confirm the clinical diagnosis. In confirmed and treated dogs, renal function and inflammatory/immune response variables should be periodically monitored. 相似文献
127.
128.
129.
130.